Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abiomed Inc (ABMD)

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,399,610
  • Shares Outstanding, K 44,957
  • Annual Sales, $ 840,880 K
  • Annual Income, $ 203,010 K
  • 60-Month Beta 0.86
  • Price/Sales 11.02
  • Price/Cash Flow 39.09
  • Price/Book 8.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.20
  • Number of Estimates 6
  • High Estimate 0.31
  • Low Estimate 0.05
  • Prior Year 1.00
  • Growth Rate Est. (year over year) -80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
161.00 +29.04%
on 04/28/20
214.40 -3.10%
on 05/26/20
+44.29 (+27.09%)
since 04/27/20
3-Month
119.01 +74.57%
on 03/23/20
214.40 -3.10%
on 05/26/20
+53.79 (+34.94%)
since 02/27/20
52-Week
119.01 +74.57%
on 03/23/20
285.77 -27.30%
on 07/31/19
-62.63 (-23.16%)
since 05/24/19

Most Recent Stories

More News
Abiomed to Hold Fireside Chat at Jefferies Virtual Healthcare Conference

Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will hold a fireside...

ABMD : 207.76 (-0.63%)
HOLX vs. ABMD: Which Stock Should Value Investors Buy Now?

HOLX vs. ABMD: Which Stock Is the Better Value Option?

HOLX : 51.39 (+0.57%)
ABMD : 207.76 (-0.63%)
Abiomed Inc Rises 2.77% on Heavy Volume: Watch For Potential Pullback

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $196.03 to a high of $202.31. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of...

ABMD : 207.76 (-0.63%)
Abiomed Inc Shares Up 29.9% Since SmarTrend's Buy Recommendation (ABMD)

SmarTrend identified an Uptrend for Abiomed Inc (NASDAQ:ABMD) on March 26th, 2020 at $151.16. In approximately 2 months, Abiomed Inc has returned 29.91% as of today's recent price of $196.36.

ABMD : 207.76 (-0.63%)
Abiomed to Host Virtual Clinical Data and Innovation Day

Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that it will host a Virtual Investor Day covering Clinical Data & Innovation on May 27, 2020...

ABMD : 207.76 (-0.63%)
PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Associated with Lower Mortality Compared to Bailout PCI

Data from more than 1,000 patients presented during the virtual 2020 Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions demonstrates Impella reduced in-hospital mortality...

ABMD : 207.76 (-0.63%)
Uptrend Call Working As Abiomed Inc Stock Rises 27.7% (ABMD)

SmarTrend identified an Uptrend for Abiomed Inc (NASDAQ:ABMD) on March 26th, 2020 at $151.16. In approximately 2 months, Abiomed Inc has returned 27.68% as of today's recent price of $193.00.

ABMD : 207.76 (-0.63%)
Abiomed Inc Rises 3.56% on Heavy Volume: Watch For Potential Pullback

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $186.99 to a high of $193.74. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of...

ABMD : 207.76 (-0.63%)
Uptrend Call Working As Abiomed Inc Stock Rises 19.1% (ABMD)

SmarTrend identified an Uptrend for Abiomed Inc (NASDAQ:ABMD) on March 26th, 2020 at $151.16. In approximately 1 month, Abiomed Inc has returned 19.10% as of today's recent price of $180.03.

ABMD : 207.76 (-0.63%)
ABIOMED (ABMD) Q4 Earnings Beat Estimates, Revenues Miss

ABIOMED's (ABMD) flagship Impella saw decline in revenues within United States in Q4.

ABMD : 207.76 (-0.63%)
EXAS : 82.11 (+1.61%)
PACB : 3.69 (+2.50%)
APHA : 4.19 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ABMD with:

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

2nd Resistance Point 215.61
1st Resistance Point 211.69
Last Price 207.76
1st Support Level 202.15
2nd Support Level 196.53

See More

52-Week High 285.77
Fibonacci 61.8% 222.07
Last Price 207.76
Fibonacci 50% 202.39
Fibonacci 38.2% 182.71
52-Week Low 119.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar